naltrexone and Thymus Neoplasms

naltrexone has been researched along with Thymus Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balog, T; Marotti, T; Martin-Kleiner, I1
Bidlack, JM; Lawrence, DM1

Other Studies

2 other study(ies) available for naltrexone and Thymus Neoplasms

ArticleYear
Dynorphin inhibits NEP activity in R1.1 mouse thymoma cells.
    Cell biochemistry and function, 2008, Volume: 26, Issue:8

    Topics: Animals; Cell Line, Tumor; Dynorphins; Mice; Naltrexone; Narcotic Antagonists; Neprilysin; Receptors, Opioid, kappa; Thiophenes; Thymoma; Thymus Neoplasms

2008
The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Animals; Cell Membrane; Cyclic AMP; Dynorphins; GTP-Binding Proteins; Mice; Naltrexone; Pertussis Toxin; Pyrrolidines; Receptors, Opioid, kappa; Sensitivity and Specificity; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Virulence Factors, Bordetella

1993